The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter Syndrome

被引：1
|
作者：
Xia, Leiming
Chen, Qian
Li, Qiao
Li, Tan
Wang, Yi
Bao, Yangyi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT041
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Chimeric Antigen Receptor-Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond
    Riddell, Stanley R.
    Jensen, Michael C.
    June, Carl H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : S2 - S5
  • [32] Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation
    Kutsch, Nadine
    Goedel, Philipp
    Voltin, Conrad-Amadeus
    Hallek, Michael
    Scheid, Christof
    Borchmann, Peter
    Holtick, Udo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (06) : 984 - 987
  • [33] Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy
    Gust, Juliane
    Finney, Olivia C.
    Li, Daniel
    Brakke, Hannah M.
    Hicks, Roxana M.
    Futrell, Robert B.
    Gamble, Danielle N.
    Rawlings-Rhea, Stephanie D.
    Khalatbari, Hedieh K.
    Ishak, Gisele E.
    Duncan, Virginia E.
    Hevner, Robert F.
    Jensen, Michael C.
    Park, Julie R.
    Gardner, Rebecca A.
    ANNALS OF NEUROLOGY, 2019, 86 (01) : 42 - 54
  • [34] Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study
    Zhai, Yinghong
    Hu, Fangyuan
    Zhu, Borui
    Xu, Jinfang
    Guo, Xiaojing
    Shi, Wentao
    Zhou, Xiang
    Zheng, Yi
    Xu, Xiao
    Ye, Xiaofei
    He, Jia
    Xu, Feng
    IMMUNOTHERAPY, 2023, 15 (06) : 443 - 456
  • [35] Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
    Ko, Andrew H.
    Jordan, Alexander C.
    Tooker, Evan
    Lacey, Simon F.
    Chang, Renee B.
    Li, Yan
    Venook, Alan P.
    Tempero, Margaret
    Damon, Lloyd
    Fong, Lawrence
    O'Hara, Mark H.
    Levine, Bruce L.
    Melenhorst, J. Joseph
    Plesa, Gabriela
    June, Carl H.
    Beatty, Gregory L.
    MOLECULAR THERAPY, 2020, 28 (11) : 2367 - 2378
  • [36] Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
    Karschnia, Philipp
    Rejeski, Kai
    Winkelmann, Michael
    Schoeberl, Florian
    Buecklein, Veit L.
    Blumenberg, Viktoria
    Schmidt, Christian
    Blobner, Jens
    von Bergwelt-Baildon, Michael
    Tonn, Joerg-Christian
    Kunz, Wolfgang G.
    Subklewe, Marion
    von Baumgarten, Louisa
    NEUROLOGY, 2022, 98 (21) : 884 - 889
  • [37] Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
    O'Hara, Mark
    Stashwick, Caitlin
    Haas, Andrew R.
    Tanyi, Janos L.
    IMMUNOTHERAPY, 2016, 8 (04) : 449 - 460
  • [38] Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer
    Yu, Feng
    Wang, Xiaoyan
    Shi, Hui
    Jiang, Maorong
    Xu, Jun
    Sun, Min
    Xu, Qinggang
    Addai, Frank Peprah
    Shi, Haifeng
    Gu, Jie
    Zhou, Yang
    Liu, Liqiong
    TUMORI JOURNAL, 2021, 107 (04): : 341 - 352
  • [39] Killing cervical cancer cells by specific chimeric antigen receptor-modified T cells
    He, Yue
    Li, Xing-Ming
    Yin, Cheng-Hong
    Wu, Yu-Mei
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 139
  • [40] Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
    Jensen, Michael C.
    Riddell, Stanley R.
    IMMUNOLOGICAL REVIEWS, 2014, 257 (01) : 127 - 144
12345